DEPLOYDatabase

Company

Ekso Bionics

American Exoskeleton company developing powered bionic suits for industrial, medical, and military applications.

Founded
2005
HQ
Richmond, California, USA
Status
public (NASDAQ: EKSO)

The verified answer

As of Aug 2026, DEPLOY verifies Ekso Bionics: 2 models, 5 deployments across 4 regions, 2 active incidents. 9 sources back the record.

Regulatory status2 FDA 510(k) clearances

Ekso Bionics holds 2 FDA 510(k) clearances, per the DEPLOY registry.

See all 2 filings

CategoryExoskeletons

Overview

American Exoskeleton company developing powered bionic suits for industrial, medical, and military applications. Publicly traded (NASDAQ: EKSO). Cloud merger approved by principal stockholders.

Verified record

Verified deployments
5 deployments on file
Active incidents
2 incidents on file

Key facts

CEO

Steven Sherman (CEO)

HQ

Richmond, California, USA

Founded

2005

Stocksee public companies

NASDAQ: EKSO (merger with Cloud approved)

Revenue

~$18.2M

Products

EksoVest (industrial), EksoNR (neurorehabilitation), exoskeleton suits for medical/industrial/military

Incidents

None found — audited

Data & sources

Patent documents

7

Web sources

2

9 sources backing this record.View all →

Relationships

Explainers

Plain-language answers to the questions people ask about Ekso Bionics, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

What is an exoskeleton robot and how does it work?
An exoskeleton is a powered wearable robotic device worn by a human that assists or amplifies the wearer's movement. Exoskeletons are not autonomous robots: the wearer's intent drives every action. The category divides between medical exoskeletons (FDA-cleared for rehabilitation and personal mobility) and industrial exoskeletons (worn by workers to reduce fatigue and injury risk).Read the full explainer →
What is Ekso Bionics and what exoskeletons does it make?
Ekso Bionics is a US medical and industrial exoskeleton manufacturer founded in 2005 (originally Berkeley Bionics) and publicly traded on NASDAQ (EKSO). The EksoNR is FDA-cleared for rehabilitation of stroke and spinal cord injury patients. EksoVest and EksoWorx target industrial workers for overhead and lifting tasks.Read the full explainer →

Founders (2)

See all founders across the registry →

Former / Previously (2)

Safety record

2 incidents on record (1 moderate, 1 minor). Most recent: Apr 2023.

moderate
1
minor
1

Most recent: Apr 2023

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Ekso Bionics (2)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operator customers (1)

Recent coverage

Ekso Bionics in third-party press

Peers

28 peers across 1 segment. Every Ekso Bionics competitor derived from shared form-factor and application-domain edges.

exoskeleton(28)

23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%